![Dr. Lana Bijelic](/uploads/profile/images/b5e1ca8b63284cf9b4b0a705aecdfaa2.png)
Dr. Lana Bijelic
Address: Carrer de Vilana, 12, 08022 Barcelona, Barcelona, Catalunya, Spain
Gender: Female
About the Doctor / Professional
Dr. Lana Bijelic is an internationally recognized expert in cytoreductive surgery and peritoneal surface malignancies. She has completed her general surgery residency in Washington DC followed by a subspecialty in surgical oncology and peritoneal surface malignancies. Dr Bijelic continued as an attending surgical oncologist with Dr Sugarbaker, a pioneer in the field, at the Washington Cancer Institute before founding a peritoneal surface malignancies program at Inova Schar Cancer Institute. Since 2021, she is the head of the peritoneal surface malignancies unit in Barcelona.
Dr Bijelic has served on committees dedicated to peritoneal surface malignancies in both American and European leading cancer societies and is the academic coordinator of the European School of Peritoneal Surface Oncology. She is certified by the American Board of Surgery.
Dr Bijelic is an active clinical researcher who has published numerous articles and lectured internationally.
Residency: Fellowship in Surgical Oncology - Washington Hospital Center
- 2021 – Present: Co-director, Peritoneal Cancer Institute - Teknon Medical Centre, Quironsalud Hospitals Group
- 2021 – Present: Chief, Peritoneal Oncology Surgery Unit CSI, Hospital Sant Joan Despi Moisés Broggi, Barcelona
- 2019 – Present: Co-lead, Peritoneal Oncology Surgery Unit - Hospital Sant Joan Despi Moisés Broggi, Barcelona
- 2015 – 2019: Section Chief , Surgical Oncology - Inova Fairfax Hospital/Inova Schar Cancer Institute
- 2007 – 2015: Attending surgeon - Washington Cancer Institute, Washington DC, USA
- Certified by the American Board of Surgery.
- M; Lana; Carmen; Ana. 2023. Wound infiltration or transversus abdominis plane block after laparoscopic radical prostatectomy: a randomized clinical trial. Anesth Pain Med (Seoul).18-2, pp.190-197.
- Ana Tejedor; Lana Bijelic; Carmen Deiros; Elisenda Pujol; Eva Bassas; Jesus Franz; Maria Jose Bernat. 2022. Feasibility and effectiveness of opioid-free anesthesia in cytoreductive surgery with or without heated intraperitoneal chemotherapy. Journal of Surgical Oncology. https://doi.org/10.1002/jso.26833
- Lana Bijelic; Isabel Ramos; Diane Goere. 2021. The Landmark Series: Surgical Treatment of Colorectal Cancer Peritoneal Metastases. Annals of Surgical Oncology. 28, pp.4140-4150.
- Pedro Barrios; Isabel Ramos; Oriol Crusellas; Domenico Sabia; Sergio Mompart; Lana Bijelic. 2021. Safe Anastomoses without Ostomies in Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy: Technical Considerations and Modifications. Annals of Surgical Oncology. 28-12, pp.7784-7792.
- Pedro Barrios; Isabel Ramos; Lana Bijelic. 2021. A Near-Zero Anastomotic Leak Rate in Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy is Achievable. Annals of Surgical Oncology. 28-12, pp.7793-7794.
- Blair Allais; Meghan Beatson; Hongkun Wang; Shandiz SHabhazi; Lana Bijelic; Sekwon Jang; Suraj Venna. 2021. Five-year survival in patients with nodular and superficial spreading melanomas in the US population. Journal of the American Academy of Dermatology. 84-4, pp.1015-1022.
- El-Sharkawy, F; Gushchin, V; Plerhoples, TA; Liu L; Emery, EL; Collins DT; (7/7) Lana Bijelic (AC). 2021. Minimally invasive surgery for T4 colon cancer is associated with better outcomes compared to open surgery in the National Cancer Database.Eur J Surg Oncol. 47-4, pp.818-827. ISSN 0748-7983. https://doi.org/10.1016/j.ejso.2020.09.003
- Loek AW de Jong; Nielka P. van Erp; Lana Bijelic. 2021. Pressurized Intraperitoneal Aerosol Chemotherapy: The Road from Promise to Proof. Clinical Cancer Research. 27-7, pp.1830-1832.
- (1/2) Bijelic, Lana; Rubio, Emilio Ramos. 2021. Tumor Necrosis in Hepatocellular Carcinoma-Unfairly Overlooked?. Annals of Surgical Oncology. 28, pp.600-601. ISSN 1068-9265. https://doi.org/10.1245/s10434-020-09402-9
- (1/2) Bijelic, Lana; Cannon, Timothy. 2020. ASO Author Reflections: Expert Surgical Evaluation is Critical for Patients with Diffuse Malignant Peritoneal Mesothelioma: Lessons Learned from Assessing Outcomes of 2000 Patients. ANNALS OF SURGICAL ONCOLOGY. 27-8, pp.2983-2984. ISSN 1068-9265. https://doi.org/10.1245/s10434-020-08251-w
- Steffen T.; Häller L.; (3/16) Bijelic L.; et al; Putora P.M.2020. Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI). Oncology (Switzerland). 99-1, pp.41-48. ISSN 0030-2414. https://doi.org/10.1159/000510098
- 0000-0001-6425-8404; Gushchin V.; Plerhoples T.A.;
- 0000-0002-0219-959X; Emery E.L.; Collins D.T.; 0000-0001-9277-5855. 2020. Minimally invasive surgery for T4 colon cancer is associated with better outcomes compared to open surgery in the National Cancer Database. European Journal of Surgical Oncology. ISSN 07487983. SCOPUS (2) https://doi.org/10.1016/j.ejso.2020.09.003
- Steffen, Thomas; Eden, Janina; (3/16) Bijelic, Lana; et al; Putora, Paul Martin. 2020. Patient Selection for Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Cancer: Consensus on Decision Making Among International Experts. CLINICAL COLORECTAL CANCER. 19, pp.277-284. ISSN 1533-0028. WOS (1) https://doi.org/10.1016/j.clcc.2020.06.010
- (1/5) Bijelic L; Darcy K; Stodghill J; Tian C; Cannon T. 2020. Predictors and Outcomes of Surgery in Peritoneal Mesothelioma: an Analysis of 2000 Patients from the National Cancer Database.Ann Surg Oncol.27-8, pp.2974-2982. ISSN 1068-9265. https://doi.org/10.1245/s10434-019-08138-5
- (1/1) Bijelic, Lana (AC). 2020. Prognosis of Resected Neuroendocrine Metastases: A Complex Puzzle Can Only be Solved One Small Piece at a Time. ANNALS OF SURGICAL ONCOLOGY. 27-10, pp.3579-3580. ISSN 1068-9265. https://doi.org/10.1245/s10434-020-08625-0
- 3 Gushchin V; Plerhoples T.; (3/3) Bijelic L. 2020. Reply to: Letter to editor- “Minimally invasive surgery for T4 colon cancer is associated with better outcomes than open surgery in national cancer database”. European Journal of Surgical Oncology. ISSN 0748-7983. https://doi.org/10.1016/j.ejso.2020.11.141
- Schuitevoerder D.; Plana A.; Izquierdo F.J.; et al; Turaga K.; (6/99)
- Bijelic L.2020. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms. Annals of Surgical Oncology. 27, pp.1753-1760. ISSN 1068-9265. SCOPUS (13) https://doi.org/10.1245/s10434-020-08316-w
- Izquierdo F.J.; Schuitevoerder D.; Plana A.; et al; Turaga K.; (28/99)
- Bijelic L.2020. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases. Annals of Surgical Oncology. 27, pp.1761-1767. ISSN 1068-9265. SCOPUS (13) https://doi.org/10.1245/s10434-020-08315-x
- Izquierdo F.J.; Plana A.; Schuitevoerder D.; et al; Turaga K.; (24/95)
- Bijelic L.2020. The Chicago Consensus on Peritoneal Surface Malignancies: Management
- of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal
- Tumors. Annals of Surgical Oncology. 27, pp.1793-1797. ISSN 1068-9265. SCOPUS
- (9) https://doi.org/10.1245/s10434-020-08319-7
- Izquierdo F.J.; Schuitevoerder D.; Plana A.; et al; Turaga K.;
- (28/99) Bijelic L.2020. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases. Annals of Surgical Oncology. 27, pp.1768-1773. ISSN 1068-9265. SCOPUS (10) https://doi.org/10.1245/s10434-020-08320-0
- Schuitevoerder D.; Plana A.; Izquierdo F.J.; et al; Turaga K.; (28/99)
- Bijelic L.2020. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Neuroendocrine Tumors. Annals of Surgical Oncology. 27, pp.1788-1792. ISSN 1068-9265. SCOPUS (10) https://doi.org/10.1245/s10434-020-08321-z
- Hoppenot C.; Schuitevoerder D.; Izquierdo F.J.; et al; Staley C.;
- (19/100) Bijelic L.2020. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms. Annals of Surgical Oncology. 27, pp.1780-1787. ISSN 1068-9265. SCOPUS (9) https://doi.org/10.1245/s10434-020-08322-y
- Schuitevoerder D.; Izquierdo F.J.; Plana A.; et al; Turaga K.; (23/99)
- Bijelic L.2020. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Peritoneal Mesothelioma. Annals of Surgical Oncology. 27, pp.1774-1779. ISSN 1068-9265. SCOPUS (8) https://doi.org/10.1245/s10434-020-08324-w
- Plana A.; Izquierdo F.J.; Schuitevoerder D.; et al; Staley C.;
- (27/100) Bijelic L.2020. The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations. Annals of Surgical Oncology. 27-6, pp.1798-1804. ISSN 1068-9265. SCOPUS (7) https://doi.org/10.1245/s10434-020-08323-x
- Plana A.; Izquierdo F.J.; Schuitevoerder D.; et al; Staley C.;
- (14/100) Bijelic L.2020. The Chicago Consensus on Peritoneal Surface Malignancies: Standards. Annals of Surgical Oncology. 27, pp.1743-1752. ISSN 1068-9265. SCOPUS
- (10) https://doi.org/10.1245/s10434-020-08325-9
- Vaz J.A.; Kashi P.K.; Movahedi-Lankarani S.; et al; Garg R.; (6/11) Bijelic L.2019. Sixteen year-old with leiomyosarcoma in a prior benign myomectomy site. Gynecologic Oncology Reports. 29, pp.126-129. ISSN 2352-5789. https://doi.org/10.1016/j.gore.2019.08.002
- Bernaiche, Tyler; Emery, Erica; (3/3) Bijelic, Lana. 2018. Practice patterns, attitudes, and knowledge among physicians regarding cytoreductive surgery and HIPEC for patients with peritoneal metastases. PLEURA AND PERITONEUM. 3-1. ISSN 2364-7671. WOS (5) https://doi.org/10.1515/pap-2017-0025
- Sugarbaker, Paul; Ihemelandu, Chukwuemeka; (3/3) Bijelic, Lana. 2016. Cytoreductive Surgery and HIPEC as a Treatment Option for Laparoscopic Resection of Uterine Leiomyosarcoma with Morcellation: Early Results. ANNALS OF SURGICAL ONCOLOGY. 23-5, pp.1501-1507. ISSN 1068-9265. WOS
- (12) https://doi.org/10.1245/s10434-015-4960-y
- Nunes, Raquel A.; Wray, Lynette; Mete, Mihriye; Herbolsheimer, Pia; Smith, Karen L.; (6/8) Bijelic, Lana; Boisvert, Marc E.; Swain, Sandra M.2016. Genomic profiling of breast cancer in African-American women using MammaPrint. BREAST CANCER RESEARCH AND TREATMENT. 159-3, pp.481-488. ISSN 0167-6806. WOS
- (6) https://doi.org/10.1007/s10549-016-3949-y
- Lana; Carmen; Ana. Wound infiltration or transversus abdominis plane block after laparoscopic radical prostatectomy: a randomized clinical trial. Anesth Pain Med (Seoul).18-2, pp.190-197.
- Congresses: Lana Bijelic; Jaume Tur; Marina Bosch; Domenico Sabia; Ana Tejedor; Carmen Roldan. IMPLEMENTATION AND IMPACT OF A CYTOREDUCTIVE SURGERY SPECIFIC, 3-TIERED ENHANCED RECOVERY AFTER SURGERY (ERAS) PROTOCOL IN A HIGH VOLUME PERITONEAL SURFACE MALIGNANCIES CENTER. The 13th International Congress on Peritoneal Surface Malignancies. PSOGI. 2023. Italia.
- Domenico Sabia 2; Jaume Tur Martinez; Elio Fabio Sanchez 1; Marina Bosch; Ana Tejedor; Lana Bijelic. PERITONEAL RECURRENCE FOLLOWING CYTOREDUCTIVE SURGERY COMBINED WITH OXALIPLATIN VS. MITOMYCIN C- BASED HIPEC FOR COLORECTAL PERITONEAL METASTASES. The 13th International Congress on Peritoneal Surface Malignancies. PSOGI. 2023. Italia.
- Centralization of care leads to optimal selection and outcomes for patients with peritoneal metastases of colorectal cancer- the Catalonian regional program experience.. ESMO 22nd World Congress on Gastrointestinal Cancer Virtual Congress,. 2020.
- Cytoreductive surgery with gastrectomy and HIPEC for gastric cancer with limited peritoneal metastases treated with neodjuvant systemic therapy is feasible and safe.. ESMO 22nd World Congress on Gastrointestinal Cancer. ESMO. 2020.
- Prognostic Factors And Outcomes Of Non-Invasive Mucinous Appendiceal Neoplasms With And Without Peritoneal Spread. Advanced Cancer Therapies 2020. Society of Surgical Oncology. 2020.
- Minimally Invasive Surgery for T4 Colon Cancer is Associated with Better Outcomes in the National Cancer Database. SSO 2018 Annual Cancer Symposium. Society of Surgical Oncology. 2018.
- Projects and Contracts: IDENTIFICATION OF PROTEOGENOMIC ALTERATIONS IN MESOTHELIOMA. (Inova Fairfax Hospital/George Mason University/WIRC). 01/10/2018- 01/10/2020. 175.000 €.
- Identification of Genomic Alterations in Diffuse Malignant Peritoneal Mesothelioma. Inova Seed Grant Program. (Inova Fairfax Hospital). 15.000 €.
- Survey of physician attitudes and practice patters regarding management of patients with peritoneal surface malignancies Role: Principal Investigator FARGO (Foundation for Applied Gastrointestinal Cancer Research). 15.000 €
- Appendix Cancer
- Cancer/Oncology Consultation
- Cytoreductive Surgery
- Cytoreductive Surgery with HIPEC
- Malignant Mesothelioma Treatment
- Ovarian Cancer with Peritoneal Metastasis
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)
- Pseudomyxoma Peritonei (PMP)
- Stomach Cancer Treatment
- Surgical Oncology